New Zealand markets closed

CERo Therapeutics Holdings, Inc. (CERO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.1900+0.0400 (+3.48%)
At close: 04:00PM EDT
1.1708 -0.02 (-1.61%)
After hours: 05:29PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Total revenue
0
0
0
Operating expenses
Research development
8,849
9,846
9,137
Selling general and administrative
2,028
2,126
2,479
Total operating expenses
10,877
11,971
11,616
Operating income or loss
-10,877
-11,971
-11,616
Income before tax
-10,752
-11,829
-10,630
Income from continuing operations
-10,752
-11,829
-10,630
Net income
-10,752
-11,829
-10,630
Net income available to common shareholders
-10,752
-11,829
-10,630
Basic EPS
-1.04
-1.15
-1.03
Diluted EPS
-1.04
-1.15
-1.03
Basic average shares
10,293
10,293
10,293
Diluted average shares
10,293
10,293
10,293